Back to Top
Anti-Mouse 4-1BBL (TKS-1) In Vivo Antibody - Low Endotoxin
$400.00 - $3,780.00
Add recommended extras
Anti-Mouse 4-1BBL (TKS-1) In Vivo Antibody - Low Endotoxin
| Species Reactivity | Mouse |
|---|---|
| Target | 4-1BBL |
| Concentration | ≤ 5.0 mg/ml |
| Isotype | Rat IgG2a Kappa |
| Host | Rat |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Application Notes | Each investigator should determine their own optimal working dilution for specific applications. |
| Applications | Blocking, Functional Assays, Western Blot |
| Storage | This antibody is stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles. |
| Endotoxin | <1.0 EU/mg as determined by the LAL method |
| Purity | ≥95% monomer by analytical SEC, >95% by SDS Page |
| Formulation | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. |
| Purification Method | This monoclonal antibody was purified using Protein G |
| Specificity | TKS-1 activity is directed against 4-1BBL (CD137L) |
| Shipping Conditions | Blue ice |
| background | 4-1BBL (CD137L) and 4-1BB (CD137) are a receptor ligand pair belonging to the tumor necrosis factor (TNF) receptor/TNF superfamily. 4-1BBL is a type II transmembrane protein expressed by activated B cells, macrophages, and dendritic cells. Members of the |
| Other names | CD137L, TNFSF9, 4-1BB Ligand, TKS-1 |
| clone | TKS-1 |
| Buffer | ICH3001-100ml ICH3002-100ml ICH3003-100ml |
| Antigen Distribution | 4-1BBL is expressed by activated B cells, macrophages, and dendritic cells |
| Immunogen | BALB/c mouse B lymphoma line 2PK-3 |
| Aggregation | Aggregation level ≤ 5% |
Write Your Own Review
Who Viewed This Also Viewed
Anti-Mouse CD22 (MB22-11) In Vivo Antibody - Low Endotoxin
$400.00 - $2,945.00
Farletuzumab Vedotin Biosimilar - Research Grade
$714.00 - $3,085.00
